We are live on ! Find out more
CYTK icon

Cytokinetics
CYTK

125 hedge funds and large institutions have $276M invested in Cytokinetics in 2015 Q4 according to their latest regulatory filings, with 34 funds opening new positions, 42 increasing their positions, 36 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

156% more call options, than puts

Call options by funds: $5.19M | Put options by funds: $2.02M

143% more first-time investments, than exits

New positions opened: 34 | Existing positions closed: 14

89% more capital invested

Capital invested by funds: $146M → $276M (+$130M)

19% more funds holding

Funds holding: 105 → 125 (+20)

17% more repeat investments, than reductions

Existing positions increased: 42 | Existing positions reduced: 36

Holders
125
Holders Change
+20
Holders Change %
+19.05%
% of All Funds
3.28%
Holding in Top 10
3
Holding in Top 10 Change
+3
Holding in Top 10 Change %
% of All Funds
0.08%
New
34
Increased
42
Reduced
36
Closed
14
Calls
$5.19M
Puts
$2.02M
Net Calls
+$3.17M
Net Calls Change
-$14K

Top Buyers

Rank Fund Capital Flow
1
EC
EcoR1 Capital
California
+$13.9M
2
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$10.6M
3
BI
BVF Inc
California
+$7.98M
4
RFC
Russell Frank Company
Washington
+$4.4M
5
EI
EAM Investors
California
+$4.11M

Top Sellers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
-$7.14M
2
Millennium Management
Millennium Management
New York
-$4.14M
3
OAM
Oxford Asset Management
United Kingdom
-$2.49M
4
SFM
Sphera Funds Management
Israel
-$2.49M
5
TC
TFS Capital
Pennsylvania
-$2.45M
Name Holding Trade Value Shares
Change 		Change in
Stake
SFM
126
Sphera Funds Management
Israel
– -$2.49M -372,250 Closed
TC
127
TFS Capital
Pennsylvania
– -$2.45M -366,042 Closed
KCM
128
Kennedy Capital Management
Missouri
– -$2.33M -348,701 Closed
NCCM
129
Nine Chapters Capital Management
New Jersey
– -$596K -89,100 Closed
AG
130
Algert Global
California
– -$490K -73,181 Closed
Alyeska Investment Group
131
Alyeska Investment Group
Illinois
– -$271K -40,485 Closed
SKK
132
Shepherd Kaplan Krochuk
Massachusetts
– -$210K -31,436 Closed
American Century Companies
133
American Century Companies
Missouri
– -$111K -16,541 Closed
Susquehanna International Group
134
Susquehanna International Group
Pennsylvania
– -$132K -13,419 Closed
LCM
135
Leisure Capital Management
California
– -$81K -12,167 Closed
Simplex Trading
136
Simplex Trading
Illinois
– -$16.1K -1,639 Closed
Royal Bank of Canada
137
Royal Bank of Canada
Ontario, Canada
– -$10K -1,567 Closed
TRCT
138
Tower Research Capital (TRC)
New York
– -$1K -174 Closed
Northwestern Mutual Wealth Management
139
Northwestern Mutual Wealth Management
Wisconsin
– -$1K -160 Closed
2 3 4 5
6

CYTK Hedge Fund Activity: Q4 2015 in Review

125 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in Cytokinetics (CYTK) for Q4 2015, worth a combined $276M — up 89% from $146M a quarter earlier.

Buyers outnumbered sellers: 34 funds opened new CYTK positions and 14 closed out — a net gain of 20 holders — while 42 added to existing stakes and 36 trimmed.

The largest buyer was EcoR1 Capital, opening a new position worth an estimated $13.9M. The largest seller was Morgan Stanley, cutting an estimated $7.14M.

  • 125 institutional investors held Cytokinetics (CYTK) as of Q4 2015, up from 105 in Q3 2015.
  • Funds reported $276M of Cytokinetics stock for Q4 2015, up 89% quarter-over-quarter.
  • 34 funds opened new Cytokinetics positions in Q4 2015 and 14 closed out, a net change of +20 holders.
  • The largest Cytokinetics buyer in Q4 2015 was EcoR1 Capital, an estimated $13.9M added.
  • The largest Cytokinetics seller in Q4 2015 was Morgan Stanley, an estimated $7.14M sold.

Based on aggregated 13F filings for Q4 2015.